[
  {
    "ts": "2026-02-05T14:00:00+00:00",
    "headline": "Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's Association (HBA)",
    "summary": "Johnson & Johnson has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen's Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the healthcare and life sciences industries.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-named-inaugural-global-140000566.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "14618edc-0078-3c5d-9d5f-f65ce7171159",
      "content": {
        "id": "14618edc-0078-3c5d-9d5f-f65ce7171159",
        "contentType": "STORY",
        "title": "Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's Association (HBA)",
        "description": "",
        "summary": "Johnson & Johnson has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen's Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the healthcare and life sciences industries.",
        "pubDate": "2026-02-05T14:00:00Z",
        "displayTime": "2026-02-05T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/447244c8b9554911efb8fa838aeec31b",
          "originalWidth": 400,
          "originalHeight": 237,
          "caption": "Johnson & Johnson was named the inaugural recipient of the HBA Global Impact Award for translating values-driven leadership into measurable impact.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KQlW96.OQYUN8NWXAzi.bw--~B/aD0yMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/447244c8b9554911efb8fa838aeec31b.cf.webp",
              "width": 400,
              "height": 237,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vpWLdWO.nN.HIMMrZ7IGdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/447244c8b9554911efb8fa838aeec31b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-named-inaugural-global-140000566.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-named-inaugural-global-140000566.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:55:47+00:00",
    "headline": "This Medical Technology Leader Sees Growth Into The 2040s",
    "summary": "Medical technology leader Halozyme Therapeutics is this week's IBD Sector Leaders selection, having bypassed two buy points and entered a buy zone. The recent IBD Stock Of The Day is rallying after the company raised its 2025 and 2026 outlook.",
    "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo-buy-zone-earnings-growth-investing-markets/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "1dc44dac-5a8b-33e4-83cc-b0992cdf9338",
      "content": {
        "id": "1dc44dac-5a8b-33e4-83cc-b0992cdf9338",
        "contentType": "STORY",
        "title": "This Medical Technology Leader Sees Growth Into The 2040s",
        "description": "",
        "summary": "Medical technology leader Halozyme Therapeutics is this week's IBD Sector Leaders selection, having bypassed two buy points and entered a buy zone. The recent IBD Stock Of The Day is rallying after the company raised its 2025 and 2026 outlook.",
        "pubDate": "2026-02-05T14:55:47Z",
        "displayTime": "2026-02-05T14:55:47Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1dc44dac-5a8b-33e4-83cc-b0992cdf9338/this-medical-technology.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4DFBQ9Ovss1qH4kurbDXSw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JlaDjExgRbJnEne6DZDYNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo-buy-zone-earnings-growth-investing-markets/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T08:00:00+00:00",
    "headline": "Big Pharma CEOs set sights on massive growth in years to come",
    "summary": "The CEOs at Johnson & Johnson, Pfizer and Merck have big plans for future revenue even as they face difficult odds in the here and now.",
    "url": "https://www.pharmavoice.com/news/big-pharma-earnings-jnj-pfizer-merck-upshot/811439/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "f11fcdb4-9358-3d9b-96b8-d482cf62a11a",
      "content": {
        "id": "f11fcdb4-9358-3d9b-96b8-d482cf62a11a",
        "contentType": "STORY",
        "title": "Big Pharma CEOs set sights on massive growth in years to come",
        "description": "",
        "summary": "The CEOs at Johnson & Johnson, Pfizer and Merck have big plans for future revenue even as they face difficult odds in the here and now.",
        "pubDate": "2026-02-05T08:00:00Z",
        "displayTime": "2026-02-05T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/5053149a4e4bf9c316a3a6b496c7b84e",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "The CEOs of Johnson & Johnson, Merck & Co. and Bristol Myers Squibb testify before a Senate panel on February 08, 2024 in Washington, DC.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s7KVePEcXgNp2dumXm81SA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/5053149a4e4bf9c316a3a6b496c7b84e.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M0bBpZR06beylE_9OYNfsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/5053149a4e4bf9c316a3a6b496c7b84e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/big-pharma-earnings-jnj-pfizer-merck-upshot/811439/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/big-pharma-ceos-set-sights-080000759.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]